Thrive Capital Management »

Neurocrine Biosciences shares owned by Thrive Capital Management

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Thrive Capital Management from 13F filings

Historical chart of Thrive Capital Management investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Thrive Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Thrive Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $467k 4.1k 115.22
2024-06-30 $548k 4.0k 137.67
2024-03-31 $242k 1.8k 137.92

More positions owned by Thrive Capital Management

Ishares Tr Core Div Grwth (DGRO)
Ishares Tr 0-5yr Hi Yl Cp (SHYG)
Vanguard Whitehall Fds High Div Yld (VYM)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds Value Etf (VTV)
Global X Fds Nasdaq 100 Cover (QYLD)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Index Fds Growth Etf (VUG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Ishares Tr Modert Alloc Etf (AOM)

View all positions for Thrive Capital Management

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences